Cite
Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer
MLA
Ji Son, et al. “Tisotumab Vedotin Extravasation Injury in a Patient with Recurrent Cervical Cancer.” Gynecologic Oncology Reports, vol. 56, no. 101525-, Dec. 2024. EBSCOhost, https://doi.org/10.1016/j.gore.2024.101525.
APA
Ji Son, Katherine E. Cain, Claire A. Marten, Kaitlin W Dwyer, Travis T. Sims, & Jolyn S. Taylor. (2024). Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer. Gynecologic Oncology Reports, 56(101525-). https://doi.org/10.1016/j.gore.2024.101525
Chicago
Ji Son, Katherine E. Cain, Claire A. Marten, Kaitlin W Dwyer, Travis T. Sims, and Jolyn S. Taylor. 2024. “Tisotumab Vedotin Extravasation Injury in a Patient with Recurrent Cervical Cancer.” Gynecologic Oncology Reports 56 (101525-). doi:10.1016/j.gore.2024.101525.